Publication | Open Access
Switch maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma: A multicenter open label phase II trial (NVALT19)
10
Citations
0
References
2019
Year
No additional data available for this publication yet. Check back later!